Skip to main content
Equibles

Apollon Wealth Management, LLC

Position in GNLX — GENELUX Corp

CIK 1764387 MOUNT PLEASANT, SC
Back to GNLX Full portfolio

Position in GNLX

as of Jun 30, 2026 · filed Jul 23, 2026
Position Value
$61,054
+$15,597 QoQ
Shares Held
20,284
+8.0% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 72 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GNLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Apollon Wealth Management, LLC holds $51,440,082 across 23 Biotechnology names. GNLX ranks #15 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 63,910 $31,746,014
2 BMRN
Biomarin Pharmaceutical Inc
 137,661 $7,876,962
3 REGN
Regeneron Pharmaceuticals, Inc.
 6,662 $4,154,023
4 RARE
Ultragenyx Pharmaceutical Inc.
 123,449 $4,121,962
5 PTCT
Ptc Therapeutics, Inc.
 6,595 $537,954
6 CRSP
CRISPR Therapeutics AG
 8,350 $455,409
7 MRNA
Moderna, Inc.
 5,260 $368,357
8 HURA
TuHURA Biosciences, Inc./NV
 156,519 $366,254

All Filings in GNLX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $61,054 20,284
2026-03-31 $45,457 18,784
2025-12-31 $81,898 18,784
2025-09-30 $78,892 18,784
2025-06-30 $53,910 18,784
2025-03-31 $50,716 18,784
2024-12-31 $39,796 16,863
2024-09-30 $33,194 14,006
2024-06-30 $27,481 14,093
2024-03-31 $90,058 14,006
2023-12-31 $196,224 14,006